Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-893-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral, male rats (no guideline, non-GLP): LD50 = 3710 mg/kg bw (RA CAS 67-03-8)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 710 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Source: CAS 67-03-8, Spince et al., 1974.
- Remarks:
- 3710 mg/kg bw, calculated from 11.0 mM/kg bw (according to Sprince et al., 1974)
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP: not classified
Applying the RA-A approach, similar results were expected for the target substance.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 710 mg/kg bw
- Quality of whole database:
- The available information comprises an adequate and reliable study from a reference substance with similar structure and intrinsic properties. The target and the source substances are thiamine derivatives with similar structure. The selected study is thus sufficient to fulfil the standard information requirements set out in Annex VII, 8.5, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for read-across
There are no reliable data available regarding acute toxicity for Reaction mass of 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-{2-[hydroxy(phosphonooxy)-phosphinyl]oxyethyl]-thiazoliumchlorid and 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-(2-phosphonooxyethyl)- thiazoliumchlorid-Dihydrat (EC 943-893-0). Read-across from an appropriate substance Thiamine, hydrochloride (CAS 67-03-8) is conducted in accordance with Regulation (EC) No 1907/2006, Annex XI, 1.5. in order to fulfil the standard data requirements defined in Regulation (EC) No 1907/2006, Annex VII, 8.5. Common functional groups, structural similarities and comparable toxicological properties (according to the joint consideration in Annex VI to CLP) of the source and target substance are the basis of read-across. A detailed analogue approach justification is provided in the technical dossier (see IUCLID Section 13).
Acute oral toxicity
CAS 67-03-8
Acute toxicity of thiamine hydrochloride was tested in male CFE albino rats (Sprince et al., 1974). In this study several doses of 4, 6, 8, 10, 11, 12, 14 and 16 mM/kg bw were tested in 15 animals per dose.Marked tremors developed within 5 - 10 minutes, persisting for another 5 - 10 minutes and were followed by a characteristic jumping behavior for about 1 - 3 minutes. Soon thereafter, the animals became limp. Based on the results of this study a LD50 value of 11 mM/kg bw corresponding to 3710 mg/kg bw was derived.
Other routes
Haley et al. (1948) investigated the source substances thiamine hydrochloride and thiamine mononitrate on its potential to exhibit toxicity after intravenous and intraperitoneal administration in mice, respectively. The determined LD50 values in mice were 329.8 mg/kg bw intraperitoneal for thiamine hydrochloride, and 387.3 mg/kg bw intraperitoneal and 84.24 mg/kg bw intravenous for thiamine mononitrate, respectively. In rabbits the intravenous lethal dose was determined to be 112.58 mg/kg bw for thiamine mononitrate and 117.45 mg/kg for thiamine hydrochloride. Symptoms by i.v. injections are hypotonia due to vasodilatation, bradycardia and respiratory arrhythmia leading to general neuromuscular inhibition. Death is caused by depression of the respiratory centre (Haley, 1948).
Besides these publications, further information was taken from the reports "Evaluation of the health aspects of thiamin hydrochloride and thiamin mononitrate as food ingredients" (FDA, 1978) and "Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin B1" (SCF, 2001). In the SCF Opinion, LD50 levels of a study from Bitsch (1997; as cited in SCF, 2001) were described to be 70-125 mg/kg bw intravenous, 317-500 mg/kg bw intraperitoneal and 300-150 mg/kg bw orally in mice for thiamine hydrochloride. Lang (1979; as cited in SCF, 2001) quoted an oral LD50 of vitamin B1 of 3000 mg/kg bw for mice. The lethal i.v. for mice were 125 mg/kg bw, for rats 250 mg/kg bw, for rabbits 300 mg/kg bw and dogs 350 mg/kg bw (McCormick, 1988; as cited in SCF, 2001). In monkeys up to 600 mg/kg bw was required to produce toxic symptoms (Gubler, 1991; as cited in SCR, 2001). According the FDA report, the oral LD50 values of thiamin were considered to be 2450 and 5000 mg/kg bw for mice, respectively, and 9500 mg/kg bw for rats. After oral administration with thiamin hydrochloride LD50 values of 3000, 5000, 6000 and 8224 mg/kg bw for mice were determined, respectively. The administration with thiamin mononitrate revealed LD50 values of 7000 mg/kg bw in mice.
Overall conclusion
The thiamin hydrochloride (CAS 67-03-8) and thiamin mononitrate (CAS 532-43-4) did not exhibit acute oral toxicity. Therefore based on the analogue approach, Reaction mass of 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-{2-[hydroxy(phosphonooxy)-phosphinyl]oxyethyl]-thiazoliumchlorid and 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-(2-phosphonooxyethyl)- thiazoliumchlorid-Dihydrat (EC 943-893-0) is not considered to exhibit hazardous properties after single exposure.
Justification for classification or non-classification
According to Article 13 of Regulation (EC) No. 1907/2006 "General Requirements for Generation of Information on Intrinsic Properties of substances", information on intrinsic properties of substances may be generated by means other than tests e.g. from information from structurally related substances (grouping or read-across), provided that conditions set out in Annex XI are met. Annex XI, "General rules for adaptation of this standard testing regime set out in Annexes VII to X” states that “substances whose physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity may be considered as a group, or ‘category’ of substances. This avoids the need to test every substance for every endpoint". Since the analogue concept is applied to Reaction mass of 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-{2-[hydroxy(phosphonooxy)-phosphinyl]oxyethyl]-thiazoliumchlorid and 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-(2-phosphonooxyethyl)- thiazoliumchlorid-Dihydrat (EC 943-893-0), data will be generated from information on reference source substance(s) to avoid unnecessary animal testing. Additionally, once the analogue read-across concept is applied, substances will be classified and labelled on this basis.
The available data on acute oral toxicity from the source substances thiamin hydrochloride (CAS 67-03-8) and thiamin mononitrate (CAS 532-43-4)do not meet the criteria for classification according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Therefore, applying the RA-A approach, the target substance Reaction mass of 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-{ 2-[hydroxy(phosphonooxy)-phosphinyl]oxyethyl]-thiazoliumchlorid and 3-[( 4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-(2-phosphonooxyethyl)- thiazoliumchlorid-Dihydrat (EC 943-893-0) is also considered no to meet the classification criteria for acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.